| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Atara Biotherapeutics Inc (NASDAQ: ATRA)
ATRA Technical Analysis
5
| As on 9th Jun 2023 ATRA STOCK Price closed @ 1.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.65 & Strong Sell for SHORT-TERM with Stoploss of 14.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATRASTOCK Price
| Open | 1.89 | Change | Price | % |
| High | 2.05 | 1 Day | 0.10 | 5.32 |
| Low | 1.86 | 1 Week | 0.45 | 29.41 |
| Close | 1.98 | 1 Month | -0.60 | -23.26 |
| Volume | 2189500 | 1 Year | -13.58 | -87.28 |
| 52 Week High 17.31 | 52 Week Low 1.50 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATRA Daily Charts |
ATRA Intraday Charts |
Whats New @ Bazaartrend |
ATRA Free Analysis |
|
|
ATRA Important Levels Intraday
| RESISTANCE | 2.35 |
| RESISTANCE | 2.23 |
| RESISTANCE | 2.16 |
| RESISTANCE | 2.08 |
| SUPPORT | 1.88 |
| SUPPORT | 1.80 |
| SUPPORT | 1.73 |
| SUPPORT | 1.61 |
ATRA Forecast May 2024
| 4th UP Forecast | 8.42 |
| 3rd UP Forecast | 6.35 |
| 2nd UP Forecast | 5.08 |
| 1st UP Forecast | 3.8 |
| 1st DOWN Forecast | 0.16 |
| 2nd DOWN Forecast | -1.12 |
| 3rd DOWN Forecast | -2.39 |
| 4th DOWN Forecast | -4.46 |
ATRA Weekly Forecast
| 4th UP Forecast | 5.97 |
| 3rd UP Forecast | 4.69 |
| 2nd UP Forecast | 3.90 |
| 1st UP Forecast | 3.11 |
| 1st DOWN Forecast | 0.85 |
| 2nd DOWN Forecast | 0.06 |
| 3rd DOWN Forecast | -0.73 |
| 4th DOWN Forecast | -2.01 |
ATRA Forecast2024
| 4th UP Forecast | 33.39 |
| 3rd UP Forecast | 23.32 |
| 2nd UP Forecast | 17.09 |
| 1st UP Forecast | 10.86 |
| 1st DOWN Forecast | -6.9 |
| 2nd DOWN Forecast | -13.13 |
| 3rd DOWN Forecast | -19.36 |
| 4th DOWN Forecast | -29.43 |
Atara Biotherapeutics Inc ( NASDAQ USA Symbol : ATRA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATRA Business Profile
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA2321 for acute myeloid leukemia; and ATA368 for human papillomavirus. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Address: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service